Get started
Author

Ryosuke Ogawa

Prognostic impact of immunohistochemical biomarkers in diffuse large B‐cell lymphoma in the rituximab era
2009 · Ritsuko Seki, Koichi Ohshima, et al. · Cancer Science · 96
PDF
Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells
2002 · Ryosuke Ogawa, Michael B. Streiff, et al. · Blood · 90
Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease
2016 · Takeshi Sugio, Koji Kato, et al. · Transplantation and Cellular Therapy · 70
PDF
Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data
2020 · Yasuo Mori, Fumiaki Jinnouchi, et al. · Bone Marrow Transplantation · 68
Human T-Cell Leukemia Virus Type I Tax Transactivates the Promoter of Human Prointerleukin-1β Gene Through Association With Two Transcription Factors, Nuclear Factor–Interleukin-6 and Spi-1
1997 · Junichi Tsukada, Masahiro Misago, et al. · Blood · 37
PDF
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib
2017 · Mariko Minami, Takeshi Arita, et al. · British Journal of Haematology · 36
PDF
Imatinib mesylate‐sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases
2004 · Takehiro Higashi, Junichi Tsukada, et al. · American Journal of Hematology · 36
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
2010 · Ritsuko Seki, Koichi Ohshima, et al. · International Journal of Hematology · 22
Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission
2017 · For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Toshihiro Miyamoto, et al. · International Journal of Hematology · 20
Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation
2021 · Goichi Yoshimoto, Yasuo Mori, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 15
Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation
2019 · Shuro Yoshida, Yuju Ohno, et al. · Annals of Hematology · 14
Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma
2014 · Tsuyoshi Muta, Shinsuke Iida, et al. · Blood · 14
TIM ‐3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation
2024 · Teppei Sakoda, Yoshikane Kikushige, et al. · Cancer Science · 13
Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study
2022 · Yasuo Mori, Naoyuki Uchida, et al. · American Journal of Hematology · 13
Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia
2019 · Koji Nagafuji, Toshihiro Miyamoto, et al. · European Journal Of Haematology · 13
Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation
2018 · For the Fukuoka Blood and Marrow Transplantation Group, Satoshi Yamasaki, et al. · International Journal of Hematology · 13
Structure and Transcriptional Regulation of Human α‐Mannosidase IIx (α‐Mannosidase II Isotype) Gene
1996 · Ryosuke Ogawa, Masahiro Misago, et al. · European Journal of Biochemistry · 11
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
2022 · Ryutaro Taenaka, Teppei Obara, et al. · Annals of Hematology · 10
PDF
Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules
2017 · Tsuyoshi Muta, Tomoyasu Yoshihiro, et al. · Internal Medicine · 9
PDF
IKZF1plus alterations are not associated with outcomes in Philadelphia‐positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL / MRD2008 trial
2023 · Yoshikiyo Ito, Hidetoshi Ozawa, et al. · European Journal Of Haematology · 7
PDF
Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report
2022 · Ryutaro Taenaka, Sakurako Shimokawa, et al. · Journal of Medical Case Reports · 7
PDF
Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma
2020 · for the Fukuoka Blood and Marrow Transplantation Group, Satoshi Yamasaki, et al. · International Journal of Hematology · 7
Characteristics of Patients With Development of Large Granular Lymphocyte Expansion Among Dasatinib-Treated Patients With Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplantation
2014 · Yoshikiyo Ito, Toshihiro Miyamoto, et al. · Clinical Lymphoma Myeloma & Leukemia · 6
A case of hepatitis B virus reactivation after elranatamab therapy in a patient with multiple myeloma
2025 · Naoaki Nishimura, Hajime Nakashima, et al. · Journal of Pharmaceutical Health Care and Sciences · 5
PDF
Familial immune‐mediated aplastic anaemia in six different families
2023 · Tatsuya Imi, Hiroki Mizumaki, et al. · eJHaem · 5
PDF
Works count: 57
Citation count: 690
H-index: 13
I10-index: 18
Year
Topic
Type